Risk factors associated with overactive bladder severity in patients with type 2 diabetes

Documenti analoghi

• Black box in overactive bladder: Central sensitization and its relationship with urinary symptom severity and quality of life
  di: Seyda T. Celenay, et al.
  Pubblicazione: (2024)
• The AUA/SUFU guideline on the diagnosis and treatment of idiopathic overactive bladder
  di: Anne P. Cameron, et al.
  Pubblicazione: (2024)
• Prospective follow‐up of overactive bladder symptoms in patients with prior SARS‐CoV‐2 infection
  di: Priya Padmanabhan, et al.
  Pubblicazione: (2024)
• Fragility of overactive bladder medication clinical trials: A systematic review
  di: Kevin D. Li, et al.
  Pubblicazione: (2024)
• Shifts in patient preference of third‐line overactive bladder therapy after introduction of the implantable tibial nerve stimulator
  di: Anjali Kapur, et al.
  Pubblicazione: (2024)